Firefly Neuroscience, Inc. Ratios

Ratios Dec2010 Dec2011 Dec2012 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 34.78%31.23%34.16%38.18%27.09%22.70%23.99%13.77%15.89%24.05%25.97%524.96%
EBT Margin 2.14%2.00%1.42%1.26%-8.23%2.32%-0.57%-7.06%2.97%-14.65%-49.84%-522.49%
EBIT Margin 2.00%1.90%1.33%1.10%-8.37%2.23%-0.70%-7.16%2.96%-17.48%-49.16%-618.07%
EBITDA Margin 2.00%1.96%1.42%1.26%-8.23%2.32%-0.57%-7.06%2.97%-7.53%-49.16%-618.07%
Operating Margin 2.00%1.90%1.33%1.10%-8.37%2.23%-0.70%-7.16%2.96%-17.48%-49.16%-618.07%
Net Margin 2.14%1.96%1.42%1.26%-8.23%2.32%-0.57%-7.06%2.97%-7.53%-103.85%-67.47%
FCF Margin 7.39%-8.87%18.95%-4.56%-4.01%7.85%-8.61%-9.10%2.58%-5.35%-74.58%-436.14%
Efficiency
Assets Average 4.19M4.31M3.94M3.74M3.38M2.70M3.07M13.57M15.67M5.31M3.62M
Equity Average 1.96M2.09M1.90M1.76M1.88M1.52M1.39M9.53M7.61M-1.06M-0.13M
Invested Capital 1.88M2.04M2.15M2.18M1.63M1.89M1.87M1.16M1.61M17.44M-1.80M0.11M0.45M
Asset Utilization Ratio 1.871.641.712.842.643.774.521.110.700.09
Leverage & Solvency
Interest Coverage Ratio 131.79-70.39-66.39-29.81
Debt to Equity 0.22-0.19-2.21
Debt Ratio 0.090.050.18
Equity Ratio 0.560.410.600.530.440.510.620.490.430.75-0.280.04-0.08
Times Interest Earned 131.79-70.39-66.39-29.81
Valuation
Enterprise Value -0.29M0.62M-0.94M-0.71M-0.55M1.97M-0.34M0.08M14.47M61.95M9.14M1.26M20.72M
Market Capitalization 1.68M1.90M1.68M1.46M1.34M4.70M1.62M1.12M16.33M66.88M9.20M3.40M22.53M
Return Ratios
Return on Sales 0.02%0.02%0.01%0.01%-0.08%0.02%-0.01%-0.07%0.03%-0.08%-1.04%-0.67%
Return on Capital Employed 0.12%0.03%-0.31%0.12%-0.03%-0.47%0.32%-0.23%-0.46%-1.11%7.42%
Return on Invested Capital 0.07%-0.14%
Return on Assets 0.04%0.02%-0.14%0.07%-0.02%-0.27%0.13%-0.08%-0.73%-0.06%-2.89%
Return on Equity 0.08%0.05%-0.29%0.14%-0.03%-0.47%0.30%-0.12%-1.50%0.32%78.65%